StockData
Soligenix, Inc. logo

Soligenix, Inc. (SNGX) stock

SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.28−0.01 (-2.67%)

Close on Nov 17, 2026Market cap $6.11MP/E –Yield –

Soligenix cash

Cash and short-term investments held at the end of each period.

Soligenix's cash was $9.81M at Jun 30, 2026. For fiscal 2025 it was $7.94M, up 1.5% from the year before. Over ten years it grew 4.9% a year on average. The highest annual figure on record is $26.04M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.94M+1.5%
FY2024Dec 31, 2024$7.82M-7.4%
FY2023Dec 31, 2023$8.45M-36.8%
FY2022Dec 31, 2022$13.36M-48.7%
FY2021Dec 31, 2021$26.04M+39.4%
FY2020Dec 31, 2020$18.68M+244.5%
FY2019Dec 31, 2019$5.42M-39.7%
FY2018Dec 31, 2018$8.98M+15.0%
FY2017Dec 31, 2017$7.81M-11.0%
FY2016Dec 31, 2016$8.77M+78.2%
FY2015Dec 31, 2015$4.92M-10.9%
FY2014Dec 31, 2014$5.53M-5.7%
FY2013Dec 31, 2013$5.86M+74.5%
FY2012Dec 31, 2012$3.36M-44.0%
FY2011Dec 31, 2011$6.00M-19.5%
FY2010Dec 31, 2010$7.45M-3.1%
FY2009Dec 31, 2009$7.69M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$9.81M+92.5%
Q1 FY2026Mar 31, 2026$6.03M-17.4%
Q4 FY2025Dec 31, 2025$7.94M+1.5%
Q3 FY2025Sep 30, 2025$10.53M+7.0%
Q2 FY2025Jun 30, 2025$5.10M-45.8%
Q1 FY2025Mar 31, 2025$7.30M+2.9%
Q4 FY2024Dec 31, 2024$7.82M-7.4%
Q3 FY2024Sep 30, 2024$9.84M-4.5%
Q2 FY2024Jun 30, 2024$9.41M-28.5%
Q1 FY2024Mar 31, 2024$7.09M-30.9%
Q4 FY2023Dec 31, 2023$8.45M-36.8%
Q3 FY2023Sep 30, 2023$10.30M-38.9%
Q2 FY2023Jun 30, 2023$13.16M-34.7%
Q1 FY2023Mar 31, 2023$10.27M-55.1%
Q4 FY2022Dec 31, 2022$13.36M-48.7%
Q3 FY2022Sep 30, 2022$16.87M-41.6%
Q2 FY2022Jun 30, 2022$20.16M-30.4%
Q1 FY2022Mar 31, 2022$22.88M-25.1%
Q4 FY2021Dec 31, 2021$26.04M+39.4%
Q3 FY2021Sep 30, 2021$28.87M+154.5%
Q2 FY2021Jun 30, 2021$28.98M+159.5%
Q1 FY2021Mar 31, 2021$30.54M+324.0%
Q4 FY2020Dec 31, 2020$18.68M+244.5%
Q3 FY2020Sep 30, 2020$11.34M+57.5%
Q2 FY2020Jun 30, 2020$11.17M+24.3%
Q1 FY2020Mar 31, 2020$7.20M-38.5%
Q4 FY2019Dec 31, 2019$5.42M+27.7%
Q1 FY2019Mar 31, 2019$7.20M+13.1%
Q4 FY2018Dec 31, 2018$8.98M+15.0%
Q3 FY2018Sep 30, 2018$11.72M+134.4%
Q2 FY2018Jun 30, 2018$4.24M-27.0%
Q1 FY2018Mar 31, 2018$6.37M-10.9%
Q4 FY2017Dec 31, 2017$7.81M-11.0%
Q3 FY2017Sep 30, 2017$5.00M-11.6%
Q2 FY2017Jun 30, 2017$5.81M+82.6%
Q1 FY2017Mar 31, 2017$7.14M+67.7%
Q4 FY2016Dec 31, 2016$8.77M–
Q3 FY2016Sep 30, 2016$5.66M–
Q2 FY2016Jun 30, 2016$3.18M–
Q1 FY2016Mar 31, 2016$4.26M–

More Soligenix figures

See a number that looks wrong?